L150-0337 Screening compound: 4-[5-({[(5-chloro-2-hydroxyphenyl)carbamoyl]methyl}sulfanyl)-1H-1,2,3,4-tetrazol-1-yl]benzoic acid

L150-0337 Screening compound: 4-[5-({[(5-chloro-2-hydroxyphenyl)carbamoyl]methyl}sulfanyl)-1H-1,2,3,4-tetrazol-1-yl]benzoic acid
L150-0337 Screening compound: 4-[5-({[(5-chloro-2-hydroxyphenyl)carbamoyl]methyl}sulfanyl)-1H-1,2,3,4-tetrazol-1-yl]benzoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound L150-0337
4-[5-({[(5-chloro-2-hydroxyphenyl)carbamoyl]methyl}sulfanyl)-1H-1,2,3,4-tetrazol-1-yl]benzoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L150-0337

Molecular Formula

C16H12ClN5O4S (C16 H12 ClN5 O4 S)

Compound Name

4-[5-({[(5-chloro-2-hydroxyphenyl)carbamoyl]methyl}sulfanyl)-1H-1,2,3,4-tetrazol-1-yl]benzoic acid

IUPAC name

4-[5-({[(5-chloro-2-hydroxyphenyl)carbamoyl]methyl}sulfanyl)-1H-1234-tetrazol-1-yl]benzoic acid

SMILES

OC(c(cc1)ccc1-n1nnnc1SCC(Nc(cc(cc1)Cl)c1O)=O)=O

InChI

InChI=1S/C16H12ClN5O4S/c17-10-3-6-13(23)12(7-10)18-14(24)8-27-16-19-20-21-22(16)11-4-1-9(2-5-11)15(25)26/h1-7,23H,8H2,(H,18,24)(H,25,26)

InChI Key

RTHSXCXBNQMFOM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD12218328

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

405.82

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.800

Distribution Coefficient, logD

-0.086

Water Solubility, LogSw

-3.40

Polar Surface Area

107.297

Acid Dissociation Constant (pKa)

4.51

Base Dissociation Constant (pKb)

-0.30

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

6.30

L150-0337 in Drug Discovery

Included in Screening Libraries

Hsp90-Targeted Library (11355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with L150-0337 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L150-0337?
Check Price and Availability of L150-0337, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L150-0337 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L150-0337
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L150-0337
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L150-0337 available by request